ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1164

Four Types of Calcium Pyrophosphate Crystals Differentially Induce IL-1beta Production By Monocytes through ATP/Potassium Efflux/ROS Dependent Pathways

Laure Campillo-Gimenez1, Pierre Gras2, Félix Renaudin3, Marion Renaud3, Lorène Télot4, Amine Mellouk5, Pierre Bobé5, Jean-Michel Camadro4, Christèle Combes2, Martine Cohen-Solal3,6, Frederic Liote3,6 and Hang-Korng Ea3,6, 1Hôpital Lariboisière, Centre Viggo Petersen, INSERM UMR1132, Paris Diderot University, Paris, France, 2ENSIACET, CIRIMAT, INPT-UPS-CNRS, Toulouse, France, 3INSERM UMR1132, Paris Diderot University, Paris, France, 4CNRS UMR7592, Jacques Monod Institute, Paris Diderot University, Paris, France, 5INSERM UMRS757, Paris Sud University, Orsay, France, 6AP-HP, Lariboisière Hospital, Rheumatology Department, Paris, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Calcium pyrophosphate dihydrate (CPPD), IL-1, inflammasome activation and monocytes, ROS

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Monoclinic and triclinic calcium pyrophosphate (m- and t-CPP) crystals are the 2 types of CPP crystals observed in human joints. Frequently asymptomatic, it can give rise to acute arthritis. Interleukin (IL-) 1β plays a pivotal role in CPP crystal-induced inflammation but how they induce IL-1β production remains unknown. IL-1β secretion occurs after its maturation by caspase-1 which is activated by NLRP3 inflammasome. NLRP3 inflammasome can be stimulated by potassium (K+) efflux, reactive oxygen species (ROS) generation, lysosomal or mitochondrial alterations. In this study we aimed to decipher how CPP crystals initiate IL-1β production.

Methods:

Four types of CPP crystals were synthesized in vitro: m- and t-CPP dihydrate (m- and t-CPPD), amorphous CPP (a-CPP) and m-CPP tetrathydrate (m-CPPT) [1]. The effects of CPP and monosodium urate (MSU) crystals – the later used as control – were assessed in human THP-1 cell line and bone marrow-derived monocytes (BMDM) from wild type (wt) and P2X7 receptor knock-out (P2X7-/-) mice. Cells were primed before stimulation with crystals. In vivo, m- and t-CPPD crystal effects were evaluated in the murine air pouch model. 

IL-1β production was measured in cell culture supernatants and air pouch lavages by ELISA. Expression of inflammatory mediator genes was analyzed by qPCR. ROS production and mitochondrial membrane potential were evaluated by microscopy and flow cytometry, using fluorescent probes (CellRox® and JC-1, respectively). Extracellular ATP (ATPe) concentration was quantified in cell culture supernatants.

Results:

In vitro, we showed that m-, t-CPPD and MSU crystals differentially induced IL-1β secretion and IL-1β, IL-6, IL-8, TNF-α, COX2 gene expression (m-CPPD > MSU > t-CPPD) while a-CPP and m-CPPTβ crystals had no effect; IL-1β production was not correlated with CPP crystal specific surface area. Similarly, these 3 inflammatory crystals induced in vivo IL-1β secretion, neutrophil and monocyte influx into the air pouch. Then, we assessed the mechanisms of CPP crystal-induced IL-1β production. First, we found that m- and t-CPPD crystals brought on an ATP release and that IL-1β production was partially inhibited by oxidized ATP. Second, m- or t-CPPD-induced IL-1β secretion was completely abrogated when K+ efflux was inhibited (cell culture with a K+-enriched medium). Although ATPe can trigger K+ efflux through P2X7 receptor opening, crystal-mediated IL-1β production was identical between wt and P2X7-/-BMDM. Finally, we demonstrated an early decrease in mitochondrial membrane potential following crystal stimulation combined with a higher intracellular ROS level. Moreover, ROS scavenger dramatically decreased IL-1β release (75% inhibition) induced by CPPD crystals.

Conclusion:

CPP crystals displayed different inflammatory properties, m-CPPD crystals being the most potent one. CPPD crystal-induced IL-1β maturation occurs through three major mechanisms including ATP release, P2X7 receptor-independent K+efflux, and mitochondrial disruption/ROS production.

[1] Gras P. et al, Eur. J. Inorg. Chem., 2013


Disclosure: L. Campillo-Gimenez, None; P. Gras, None; F. Renaudin, None; M. Renaud, None; L. Télot, None; A. Mellouk, None; P. Bobé, None; J. M. Camadro, None; C. Combes, None; M. Cohen-Solal, None; F. Liote, None; H. K. Ea, None.

To cite this abstract in AMA style:

Campillo-Gimenez L, Gras P, Renaudin F, Renaud M, Télot L, Mellouk A, Bobé P, Camadro JM, Combes C, Cohen-Solal M, Liote F, Ea HK. Four Types of Calcium Pyrophosphate Crystals Differentially Induce IL-1beta Production By Monocytes through ATP/Potassium Efflux/ROS Dependent Pathways [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/four-types-of-calcium-pyrophosphate-crystals-differentially-induce-il-1beta-production-by-monocytes-through-atppotassium-effluxros-dependent-pathways/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/four-types-of-calcium-pyrophosphate-crystals-differentially-induce-il-1beta-production-by-monocytes-through-atppotassium-effluxros-dependent-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology